SAB Biotherapeutics Provides Company Update for Q1 2022 Financial Results
Go back to SAB Biotherapeutics Provides Company Update for Q1 2022 Financial Results| (NASDAQ: SABS) | Delayed: 3.81 +0.19 (5.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.62 | 52 Week High | $ | |||
| Open | $3.65 | 52 Week Low | $ | |||
| Day High | $3.81 | P/E | N/A | |||
| Day Low | $3.61 | EPS | $ | |||
| Volume | 359,374 | |||||
| (NASDAQ: SABSW) | Delayed: 0.03 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.03 | 52 Week High | $ | |||
| Open | $0.04 | 52 Week Low | $ | |||
| Day High | $0.04 | P/E | N/A | |||
| Day Low | $0.03 | EPS | $ | |||
| Volume | 50,324 | |||||

